Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Zhizhong Z. Pan Image

      Zhizhong Z. Pan, Ph.D.

      Department of Pain Medicine, Division of Anesthesiology, Critical Care Medicine, and Pain Medicine

      Present Title & Affiliation

      Primary Appointment

      Professor, Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1993Vollum Institute and Department of Physiology, Oregon Health Sciences University, Portland, Oregon, US, Neuroscience, Ph.D
      1985Shanghai Institute of Physiology, Chinese Academy of Sciences, Shanghai, CN, Physiology, Master of Science
      1982Jiangxi University, Jiangxi, CN, Biology, Bachelor of Science

      Postgraduate Training

      1993-1997Postdoctoral Fellowship, Neuroscience, University of California at San Francisco, San Francisco, California

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Department of Pain Medicine, Division of Anesthesiology, Critical Care and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012

      Faculty Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, 2000 - 2012

      Assistant Professor, Department of Anesthesiology, Division of Anesthesiology, Critical Care and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - 2006

      Adjunt Assistant Professor, Department of Neurology, University of California, San Francisco, CA, 1997 - 2000

      Staff Research Associate, Vollum Institute, Oregon Health Sciences University, Portland, OR, 1987 - 1990

      Assistant Investigator, Shanghai Institute of Physiology, Chinese Academy of Sciences, Shanghai, 1986 - 1987

      Staff Researcher, Shanghai Institute of Physiology, Chinese Academy of Sciences, Shanghai, 1985 - 1986

      Administrative Appointments/Responsibilities

      Seminar Coordinator, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2007

      Intramural Institutional Committee Activities

      Member, Annual Postdoctoral Science Symposium Reviews, The University of Texas MD Anderson Cancer Center, 2019

      Member, Division Faculty Recruitment Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2022

      Member, Division Research Development Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2023

      Reviewer, Provost Distinguished Research Faculty Mentoring Award, The University of Texas MD Anderson Cancer Center, 2017

      Member, Internal Review Study Section (INTEREST), The University of Texas MD Anderson Cancer Center, 2017

      Member, Faculty Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2022

      Reviewer, Endowed Fellowship Award Reviewer, The University of Texas MD Anderson Cancer Center, 2015 - 2017

      Member, Executive Committee, Gulf Coast Consortium for Transnational Pain Research, The University of Texas MD Anderson Cancer Center, 2012 - 2018

      Member, Thesis Supervisory Committee, GSBS for PhD Students, The University of Texas MD Anderson Cancer Center, 2012 - 2014

      Member, Admission Committee, GSBS Neuroscience Program, The University of Texas MD Anderson Cancer Center, 2008 - 2014

      Member, Division Research Committee, The University of Texas MD Anderson Cancer Center, 2006 - Present

      Chair, Thesis Examining Committee, GSBS for PhD Students, The University of Texas MD Anderson Cancer Center, 2005 - Present

      Member, Thesis Supervisory Committee, GSBS for PhD Students, The University of Texas MD Anderson Cancer Center, 2005 - 2009

      Member, Institutional Animal Care and Use Committee (IACUC), The University of Texas MD Anderson Cancer Center, 2005 - 2008

      Chair, Thesis Advisory Committee, Examining Committee for PhD Students, The University of Texas MD Anderson Cancer Center, 2005 - 2006

      Extramural Institutional Committee Activities

      Member, Thesis Advisory Committee, GSBS for PhD Students, The University of Texas MD Anderson Cancer Center, 2010 - 2017

      Member, Thesis Advisory Committee, GSBS for PhD Students, The University of Texas MD Anderson Cancer Center, 2004 - 2006

      Editorial Activities

      Editor, Molecular Pain, 2004 - Present

      Honors & Awards

      1993National Research Service Award, NIH
      1991Oregon N.L. Tartar Research Award, State of Oregon

      Professional Memberships

      International Association for the Study of Pain

      2004 - 2020

      Society for Neuroscience

      1993 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2020. Impact of pain on opioid use. Invited. College Station, Texas, US.
      2. 2015. Pain and Opioids: From Gene to Behavior. Conference. Pain and Opioids: From Gene to Behavior. Houston, TX, US.
      3. 2014. Bridging the Gap Between Pain Research and Pain Managment. Conference. Bridging the Gap Between Pain Research and Pain Managment. Houston, Texas, US.
      4. 2007. Pain and Opioid Addiction. Conference. Pain and Opioid Addiction. Houston, Texas, US.
      5. 2006. Opioid Analgesics: Medical Use and Non-Medical Abuse. Conference. Opioid Analgesics: Medical Use and Non-Medical Abuse. Houston, Texas, US.
      6. 2005. Opioid Receptor Functions. Conference. Opioid Receptor Functions. Houston, TX, US.
      7. 2005. Chronic Opioid and Pain. Conference. Chronic Opioid and Pain. Houston, Texas, US.
      8. 2003. Mechanisms of Opioid Tolerance and Dependence. Conference. Mechanisms of Opioid Tolerance and Dependence. Houston, Texas, US.
      9. 2000. How Opioids Inhibit Pain. Conference. How Opioids Inhibit Pain. Houston, Texas, US.

      National Presentations

      1. 2018. Brain Circuits for Emotion and Pain. Conference. Vollum Symposium. Portland, OR, US.
      2. 2016. Exploring the Epigenetic Mechanisms for Individual Pain Vulnerability. Conference. 8th Scientific Meeting of the TMJ Association with FASEB and NIDCR. Bethesda, MD, US.
      3. 2015. Dissecting the Brain's Pain Circuits. Conference. International Narcotics Research Conference. Phoenix, AZ, US.
      4. 2010. Signaling Mechanisms for DOR Trafficking and Function. Conference. Spring Pain Research Conference. Grand Cayman.
      5. 2006. Central Amygdala in Drug Addiction and Pain Modulation. Conference. Annual meeting of American Pain Society. San Antonio, TX, US.
      6. 2006. Central Amygdala Function in Pain modulation. Conference. Spring Pain Research Conference. Grand Cayman.

      International Presentations

      1. 2019. Epigenetic Mechanisms of Pain vulnerability. Invited. Xuzhou, CN.
      2. 2015. Targeting Brain Circuits for Pain and Emotion. Conference. 6th Asian Pain Conference. Suzhou, CN.
      3. 2014. Repression mechanisms in epigenetic regulation of pain. Conference. 15th Congress on Pain. Buenos Aires, AR.
      4. 2014. Pain Increases Reward Response to Opioids through a Shared Epigenetic Pathway. Conference. Pain Increases Reward Response to Opioids through a Shared Epigenetic Pathway. Montreal, CA.
      5. 2014. Pain Facilitates Opioid Reward via an Epigenetic Mechanism. Conference. Symposia for Chinese Neuroscientists Worldwide. Suzhou, CN.
      6. 2012. Epigenetic Mechanisms for Chronic Pain and Drug Addiction. Conference. International symposium of the society of Chinese bioscientists. Nanjing, CN.
      7. 2011. Epigenetic Mechanisms of Chronic Pain. Conference. Research Symposium of International Association for the Study of Pain. Shanghai, CN.
      8. 2010. Delta-Opioid Receptor Trafficking and Functions. Conference. Symposium for Chinese Neuroscientists Worldwide. Nanchang, CN.
      9. 2007. Central Amygdala: Conjunctive Modulation of Pain and Drug Reward. Conference. International Conference of Neurons and Brain Diseases. Toronto, CA.
      10. 2003. Synaptic Adaptations and Mechanisms of Analgesic Tolerance to Chronic Opioids. Conference. Annual meeting of International Narcotics Research Conference. Perpignan, FR.

      Formal Peers

      1. 2018. Pain, Emotion and Underlying Brain Circuits and Mechanisms. Invited. Newark, NJ, US.
      2. 2016. Dissecting the Brain's Pain Circuits for Pain and Opioid Reward. Invited. Lubbock, TX, US.
      3. 2015. Epigenetic Regulation of Sensory and Affective Pain. Invited. New York, NY, US.
      4. 2014. Epigenetic Regulation of Sensory and Affective Pain. Invited. Shanghai, CN.
      5. 2013. How Pain Affects Opioid Reward. Invited. Baltimore, MD, US.
      6. 2012. Epigenetic mechanisms for chronic pain and opioid reward. Invited. Galveston, TX, US.
      7. 2011. Understanding the development of chronic pain and opioid addiction. Invited. Shanghai, CN.
      8. 2010. Functions of Delta-Opioid Receptors in Pain and Addiction. Invited. Shanghai, CN.
      9. 2007. Opioid Receptor Trafficking. Invited. Houston, TX, US.
      10. 2007. Central Amygdala in Opioid and Alcohol Addiction and Modulation of Pain. Invited. Emeryville, CA, US.
      11. 2005. Delta-Opioid Receptor Trafficking and Pain Modulation. Invited. Iowa City, IA, US.
      12. 2004. Cyclic AMP-Mediated Pain and Opioid Tolerance. Invited. San Francisco, CA, US.
      13. 2004. Bi-Directional Modulation of Pain by Opioids. Invited. Beijing, CN.
      14. 2004. Synaptic Mechanisms of Opioid Analgesic Tolerance and Dependence. Invited. Galveston, TX, US.
      15. 2003. Opioid Modulation of Synaptic Transmission and Pain. Invited. Houston, TX, US.
      16. 1999. Roles of Opioid Receptors in Opioid Analgesia and Addiction. Invited. Bethesda, MD, US.
      17. 1997. Opposing Functions of Opioid Receptors. Invited. Minneapolis, MN, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2024 - 2028
      Title:Cortical and Amygdala Circuit Mechanisms for Chronic Pain
      Funding Source:DOD
      Role:PI
      ID:HT94252410686
      Date: 2022 - 2027
      Title:Targeting Tiam1-mediated synaptic plasticity for relief of opioid tolerance,
      Funding Source:NIH/NIDA
      Role:Co-I
      ID:R01-DA056673
      Date: 2019 - 2024
      Title:Dnmt3a as an epigenetic target for chronic pain treatment
      Funding Source:NIH/NINDS
      Role:PI
      ID:R01- NS113256
      Date: 2016 - 2021
      Title:Epigenetic Basis for Pain Vulnerability
      Funding Source:NIH/NIDCR
      Role:PI
      ID:R01DE025943
      Date: 2009 - 2014
      Title:Synaptic mechanisms for interactions of chronic pain and opioid addiction
      Funding Source:NIH/NIDA
      Role:PI
      ID:R01-DA027541
      Date: 2009 - 2011
      Title:Impact of Pain on Sensitivity to Opioid Reward
      Funding Source:NIH/NIDA
      Role:PI
      ID:R21-DA025826
      Date: 2008 - 2013
      Title:Delta-opioid receptor trafficking and Pain inhibition
      Funding Source:NIH/NIDA
      Role:PI
      ID:R01-023069
      Date: 2006 - 2008
      Title:Mechanisms of Cytokine-induced Pain
      Funding Source:Institutional Research Grant MDACC
      Role:PI
      Date: 2001 - 2007
      Title:Opioid Receptors and the Mechanisms of Opioid Tolerance
      Funding Source:NIH/NIDA
      Role:PI
      ID:R01-DA14524

      Selected Publications

      Peer-Reviewed Articles

      1. Ge J, Cai YQ, Pan ZZ. A Dnmt3a-mediated epigenetic mechanism for chronic pain-induced anxiety behavior in mice. Cells(15):1304, 2026. e-Pub 2026.
      2. Guanxing Chen, Xin Guan, Hua Wei, You-Qing Cai, Pan ZZ, Hui-Lin Pan, Jiusheng Yan. Transgenic expression of BK channel auxiliary LRRC26 subunit in the forebrain causes locomotor hyperactivity and cognitive defects. eNeuro. e-Pub 2026.
      3. Cai, Y, Ge, J, Pan, ZZ. The projection from dorsal medial prefrontal cortex to basolateral amygdala promotes behaviors of negative emotion in rats. Frontiers in Neuroscience 18, 2024. e-Pub 2024. PMID: 38327845.
      4. Karimi, T, Pan, ZZ, Potaman, VN, Alt, EU. Conversion of Unmodified Stem Cells to Pacemaker Cells by Overexpression of Key Developmental Genes. Cells 12(10), 2023. e-Pub 2023. PMID: 37408215.
      5. Ge, J, Cai, Y, Pan, ZZ. Synaptic plasticity in two cell types of central amygdala for regulation of emotion and pain. Frontiers in Cellular Neuroscience 16, 2022. e-Pub 2022. PMID: 36385947.
      6. Tao, W, Chen, C, Wang, Y, Zhou, W, Jin, Y, Mao, Y, Wang, H, Wang, L, Xie, W, Zhang, X, Li, J, Li, J, Li, X, Tang, ZQ, Zhou, C, Pan, ZZ, Zhang, Z. MeCP2 mediates transgenerational transmission of chronic pain. Progress in Neurobiology 189, 2020. e-Pub 2020. PMID: 32200043.
      7. Zhou, C, Wu, Y, Ding, X, Shi, N, Cai, Y, Pan, ZZ. SIRT1 decreases emotional pain vulnerability with associated CaMKIIα deacetylation in central amygdala. Journal of Neuroscience 40(10):2332-2342, 2020. e-Pub 2020. PMID: 32005763.
      8. Hou, Y, Cai, Y, Pan, ZZ. GluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain. Neuroscience 426:141-153, 2020. e-Pub 2020. PMID: 31863796.
      9. Cai, Y, Hou, Y, Pan, ZZ. GluA1 in central amygdala increases pain but inhibits opioid withdrawal-induced aversion. Molecular pain 16, 2020. e-Pub 2020. PMID: 32162577.
      10. Zhu, X, Zhou, W, Jin, Y, Tang, H, Cao, P, Mao, Y, Xie, W, Zhang, X, Zhao, F, Luo, MH, Wang, H, Li, J, Tao, W, Farzinpour, Z, Wang, L, Li, X, Li, J, Tang, ZQ, Zhou, C, Pan, ZZ, Zhang, Z. A Central Amygdala Input to the Parafascicular Nucleus Controls Comorbid Pain in Depression. Cell Reports 29(12):3847-3858.e5, 2019. e-Pub 2019. PMID: 31851918.
      11. Lu L, Marisetty A, Liu B, Kamal MM, Gumin J, Veo B, Cai Y, Kassem DH, Weng C, Maynard ME, Hood KN, Fuller GN, Pan ZZ, Cykowski MD, Dash PK, Majumder S. REST overexpression in mice causes deficits in spontaneous locomotion. Sci Rep 8(1):12083, 2018. e-Pub 2018. PMID: 30108242.
      12. Cai YQ, Wang W, Paulucci-Holthauzen A, Pan ZZ. Brain Circuits Mediating Opposing Effects on Emotion and Pain. J Neurosci 38(28):6340-6349, 2018. e-Pub 2018. PMID: 29941444.
      13. Wang W, Li C, Cai Y, Pan ZZ. Pain vulnerability and DNA methyltransferase 3a involved in the affective dimension of chronic pain. Mol Pain 13:1744806917726713, 2017. e-Pub 2017. PMID: 28849714.
      14. Hou YY, Cai YQ, Pan ZZ. Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of GluA1 in rat central amygdala. J Neurosci 35(8):3689-700, 2015. e-Pub 2015. PMID: 25716866.
      15. Cai YQ, Wang W, Hou YY, Pan ZZ. Optogenetic activation of brainstem serotonergic neurons induces persistent pain sensitization. Mol Pain 10:70, 2014. e-Pub 2014. PMID: 25410898.
      16. Zhang Z, Tao W, Hou YY, Wang W, Lu YG, Pan ZZ. Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function. Neuropsychopharmacology 39(9):2263-71, 2014. e-Pub 2014. PMID: 24686896.
      17. Zhang Z, Tao W, Hou YY, Wang W, Kenny PJ, Pan ZZ. MeCP2 repression of G9a in regulation of pain and morphine reward. J Neurosci 34(27):9076-87, 2014. e-Pub 2014. PMID: 24990928.
      18. Zhang Z, Wang X, Wang W, Lu YG, Pan ZZ. Brain-derived neurotrophic factor-mediated downregulation of brainstem K+-Cl- cotransporter and cell-type-specific GABA impairment for activation of descending pain facilitation. Mol Pharmacol 84(4):511-20, 2013. e-Pub 2013. PMID: 23847084.
      19. Cai YQ, Wang W, Hou YY, Zhang Z, Xie J, Pan ZZ. Central amygdala GluA1 facilitates associative learning of opioid reward. J Neurosci 33(4):1577-88, 2013. e-Pub 2013. PMID: 23345231.
      20. Bie B, Wang Y, Cai YQ, Zhang Z, Hou YY, Pan ZZ. Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward. Neuropsychopharmacology 37(13):2780-8, 2012. e-Pub 2012. PMID: 22871918.
      21. Zhang Z, Pan ZZ. Signaling Cascades for Delta-opioid Receptor-mediated Inhibition of GABA Synaptic Transmission and Behavioral Antinociception. Mol Pharmacol 81(3):375-83, 2012. e-Pub 2012. PMID: 22144670.
      22. Metzele R, Alt C, Bai X, Yan Y, Zhang Z, Pan Z, Coleman M, Vykoukal J, Song YH, Alt E. Human adipose tissue-derived stem cells exhibit proliferation potential and spontaneous rhythmic contraction after fusion with neonatal rat cardiomyocytes. FASEB J 25(3):830-9, 2011. e-Pub 2011. PMID: 21059751.
      23. Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ. Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 17(11):1448-55, 2011. e-Pub 2011. PMID: 21983856.
      24. Gopalakrishnan V, Bie B, Sinnappah-Kang ND, Adams H, Fuller GN, Pan ZZ, Majumder S. Myoblast-Derived Neuronal Cells Form Glutamatergic Neurons in the Mouse Cerebellum. Stem Cells 28(10):1839-47, 2010. e-Pub 2010. PMID: 20799335.
      25. Bie B, Zhang Z, Cai YQ, Zhu W, Zhang Y, Dai J, Lowenstein CJ, Weinman EJ, Pan ZZ. Nerve growth factor-regulated emergence of functional delta-opioid receptors. J Neurosci 30(16):5617-28, 2010. e-Pub 2010. PMID: 20410114.
      26. Zhang Z, Pan ZZ. Synaptic mechanism for functional synergism between delta- and mu-opioid receptors. J Neurosci 30(13):4735-45, 2010. e-Pub 2010. PMID: 20357124.
      27. Bie B, Zhu W, Pan ZZ. Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience 160(2):348-58, 2009. e-Pub 2009. PMID: 19258026.
      28. Bie B, Zhu W, Pan ZZ. Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J Pharmacol Exp Ther 329(1):290-6, 2009. e-Pub 2009. PMID: 19168708.
      29. Weng HR, Chen JH, Pan ZZ, Nie H. Glial glutamate transporter 1 regulates the spatial and temporal coding of glutamatergic synaptic transmission in spinal lamina II neurons. Neuroscience 149(4):898-907, 2007. e-Pub 2007. PMID: 17935889.
      30. Bai X, Ma J, Pan Z, Song YH, Freyberg S, Yan Y, Vykoukal D, Alt E. Electrophysiological properties of human adipose tissue-derived stem cells. Am J Physiol Cell Physiol 293(5):C1539-50, 2007. e-Pub 2007. PMID: 17687001.
      31. Zhu W, Bie B, Pan ZZ. Involvement of non-NMDA glutamate receptors in central amygdala in synaptic actions of ethanol and ethanol-induced reward behavior. J Neurosci 27(2):289-98, 2007. e-Pub 2007. PMID: 17215388.
      32. Ma JY, Pan ZZ. Contribution of brainstem GABA(A) synaptic transmission to morphine analgesic tolerance. Pain 122(1-2):163-73, 2006. e-Pub 2006. PMID: 16527406.
      33. Ma JY, Zhang Y, Kalyuzhny AE, Pan ZZ. Emergence of functional &-opioid receptors induced by chronic morphine. Mol. Pharmacol 69:1137-1145, 2006. e-Pub 2006.
      34. Bie B, Peng Y, Zhang Y, Pan ZZ. cAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J Neurosci 25(15):3824-32, 2005. e-Pub 2005. PMID: 15829634.
      35. Bie B, Pan ZZ. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats. Mol Pain 1(1):7, 2005. e-Pub 2005. PMID: 15813995.
      36. Zhu W, Pan ZZ. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133(1):97-103, 2005. e-Pub 2005. PMID: 15893634.
      37. Watanabe Y, Kameoka S, Gopalakrishnan V, Aldape KD, Pan ZZ, Lang FF, Majumder S. Conversion of myoblasts to physiologically active neuronal phenotype. Genes Dev 18(8):889-900, 2004. e-Pub 2004. PMID: 15078815.
      38. Zhu W, Pan ZZ. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 127(4):871-9, 2004. e-Pub 2004. PMID: 15312899.
      39. Pan ZZ. An intensified descending pain-facilitating pathway. Drug Discovery Today: Disease Models 1:121-125, 2004. e-Pub 2004.
      40. Bie B, Pan ZZ. Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors. J Neurosci 23(19):7262-8, 2003. e-Pub 2003. PMID: 12917359.
      41. Bie B, Fields HL, Williams JT, Pan ZZ. Roles of alpha1- and alpha2-adrenoceptors in the nucleus raphe magnus in opioid analgesia and opioid abstinence-induced hyperalgesia. J Neurosci 23(21):7950-7, 2003. e-Pub 2003. PMID: 12944526.
      42. Pan ZZ. Kappa-opioid receptor-mediated enhancement of the hyperpolarization-activated current (I(h)) through mobilization of intracellular calcium in rat nucleus raphe magnus. J Physiol 548(Pt 3):765-75, 2003. e-Pub 2003. PMID: 12651920.
      43. Pan Z, Hirakawa N, Fields HL. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26(2):515-22, 2000. e-Pub 2000. PMID: 10839369.
      44. Pan ZZ, Tershner SA, Fields HL. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature 389(6649):382-5, 1997. e-Pub 1997. PMID: 9311779.
      45. Pan ZZ, Fields HL. Endogenous opioid-mediated inhibition of putative pain-modulating neurons in rat rostral ventromedial medulla. Neuroscience 74(3):855-62, 1996. e-Pub 1996. PMID: 8884781.
      46. Pan ZZ, Grudt TJ, Williams JT. Alpha 1-adrenoceptors in rat dorsal raphe neurons: regulation of two potassium conductances. J Physiol 478 Pt 3:437-47, 1994. e-Pub 1994. PMID: 7525947.
      47. Pan ZZ, Williams JT. Muscarine hyperpolarizes a subpopulation of neurons by activating an M2 muscarinic receptor in rat nucleus raphe magnus in vitro. J Neurosci 14(3 Pt 1):1332-8, 1994. e-Pub 1994. PMID: 8120628.
      48. Pan ZZ, Tong G, Jahr CE. A false transmitter at excitatory synapses. Neuron 11(1):85-91, 1993. e-Pub 1993. PMID: 8101712.
      49. Pan ZZ, Wessendorf MW, Williams JT. Modulation by serotonin of the neurons in rat nucleus raphe magnus in vitro. Neuroscience 54(2):421-9, 1993. e-Pub 1993. PMID: 8101640.
      50. Pan ZZ, Williams JT, Osborne PB. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J Physiol 427:519-32, 1990. e-Pub 1990. PMID: 1976803.
      51. Pan ZZ, Williams JT. Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro. J Pharmacol Exp Ther 251(1):56-62, 1989. e-Pub 1989. PMID: 2795470.
      52. Pan ZZ, Colmers WF, Williams JT. 5-HT-mediated synaptic potentials in the dorsal raphe nucleus: interactions with excitatory amino acid and GABA neurotransmission. J Neurophysiol 62(2):481-6, 1989. e-Pub 1989. PMID: 2788717.
      53. Pan ZZ, Williams JT. GABA- and glutamate-mediated synaptic potentials in rat dorsal raphe neurons in vitro. J Neurophysiol 61(4):719-26, 1989. e-Pub 1989. PMID: 2723717.
      54. Williams JT, Colmers WF, Pan ZZ. Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vitro. J Neurosci 8(9):3499-506, 1988. e-Pub 1988. PMID: 3171686.
      55. Leger, L, Pan ZZ, Jouvet M, Chiang CY. Anatomical relationships between enkephalin-immunoreactive nerve fibers and serotonin-containing cell bodies in rat nucleus raphe magnus. Chin. J Physiol Sciences 2:143-147, 1986. e-Pub 1986.
      56. Chiang CY, Pan ZZ. Differential responses of serotonergic and non-serotonergic neurons in nucleus raphe magnus to systemic morphine in rats. Brain Res 337(1):146-50, 1985. e-Pub 1985. PMID: 4005602.

      Invited Articles

      1. Pan ZZ. A Life Switch in Pain. Pain(153):738-739, 2012. e-Pub 2012. PMID: 22342072.

      Review Articles

      1. Pan ZZ. Transcriptional control of Gad2. Transcription 3(2):68-72, 2012. e-Pub 2012. PMID: 22414751.
      2. Bie B, Pan ZZ. Trafficking of central opioid receptors and descending pain inhibition. Mol Pain 3:37, 2007. e-Pub 2007. PMID: 18053223.
      3. Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19(3):94-8, 1998. e-Pub 1998. PMID: 9584625.
      4. Pan ZZ, Jiang ZY. [Anatomic and neurophysiologic studies on nucleus raphe magnus]. Sheng Li Ke Xue Jin Zhan 17(3):199-205, 1986. e-Pub 1986. PMID: 3541177.

      Other Articles

      1. Lu, L, Marisetty, AL, Liu, B, Kamal, MM, Gumin, J, Veo, BL, Cai, Y, Kassem, DH, Weng, C, Maynard, ME, Hood, KN, Fuller, GN, Pan, ZZ, Cykowski, MD, Dash, PK, Majumder, S Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion. Scientific reports 12(1), 2022. PMID: 36526687.

      Abstracts

      1. Li CY, Zhou CH, Cai YQ, Pan ZZ. Pain vulnerability is inherent in affective dimension of chronic pain, 2017. e-Pub 2017.
      2. Cai YQ, Wang W, Pan ZZ. Exploring the epigenetic mechanisms for individual pain vulnerability(13):1-40, 2017. e-Pub 2017.
      3. Cai YQ, Pan ZZ. Optogenetic stimulation of the excitatory paracrachial projections to central maygdala induces anxiety- and depression-like behaviors in rats, 2016. e-Pub 2016.
      4. Hou YY, Cai YQ, Pan ZZ. AMPA receptors in central amygdala mediate pain-induced suppression of opioid reward, 2012. e-Pub 2012.
      5. Zhang Z, Hou YY, Zia Y, Wang W, Pan ZZ. Down-regulation of GABAergic function in the CeA mediates morphine reward, 2012. e-Pub 2012.
      6. Cai YQ, Hou YY, Pan ZZ. GluR1 of AMPA receptors in rostral ventromedial medulla mediates descending pain inhibition in rats with persistent pain, 2012. e-Pub 2012.
      7. Zhang Z, Pan ZZ. Cell-type specific downregulation of KCC2 reduces GABAergic transmission in brainstem neurons after persistent inflammatory pain, 2011. e-Pub 2011.
      8. Cai YQ, Hou YY, Pan ZZ. Upregulation of central amygdala AMPA GluR1 subunits facilitates behavior of opioid reward, 2011. e-Pub 2011.
      9. Bie B, Zhang Z, Cai YQ, Reyes F, Pan ZZ. Delta-Opioid Receptor Trafficking and Functions, 2010. e-Pub 2010.
      10. Zhang Z, Pan ZZ. Signaling cascade for delta-opioid receptor-induced inhibition of GABA synaptic transmission, 2010. e-Pub 2010.
      11. Zhang, Z, Pan ZZ. Presynaptic mechanisms for synergistic inhibition of GABA synaptic transmission by delta- and mu-opioid receptors, 2009. e-Pub 2009.
      12. Zhu W, Bie B, Pan, ZZ. Central amygdala: conjunctive modulation of pain and drug reward, 2007. e-Pub 2007.
      13. Bie B, Pan ZZ. Alcohol induces trafficking of delta-opioid receptors in central amygdala, 2007. e-Pub 2007.
      14. Chen JH, Pan ZZ, Weng HR. Excitatory postsynaptic activities in substantia gelatinosa neurons are regulated by glial glutamate transporters, 2006. e-Pub 2006.
      15. Zhu, W, Pan ZZ. Chronic ethanol enhances glutamate synaptic transmission and ethanol inhibition in neurons of rat central amygdala, 2005. e-Pub 2005.
      16. Ma, JY, Pan ZZ. Up-regulation of delta-opioid receptor function in the nucleus raphe magnus of morphine-tolerant rats, 2005. e-Pub 2005.
      17. Ma, JY, Pan ZZ. Increased GABA synaptic transmission through upregulation of the cAMP pathway in morphine-dependent rats, 2004. e-Pub 2004.
      18. Zhu, W, Pan ZZ. Inhibition of non-NMDA glutamatergic synaptic transmission by ethanol in rat central nucleus of the amygdala, 2004. e-Pub 2004.
      19. Bie, B, Pan ZZ. Cyclic AMP-dependent pathway modulates glutamatergic synaptic transmission during morphine withdrawal, 2004. e-Pub 2004.
      20. Bie, B, Pan ZZ. Chronic morphine treatment alters glutamatergic synaptic transmission in rat nucleus raphe magnus, 2003. e-Pub 2003.
      21. Zhu, W, Pan ZZ. Presynaptic inhibition of glutamate synaptic transmission by mu-opioid receptors in rat central nucleus of the amygdala, 2003. e-Pub 2003.
      22. Ma, JY, Bie B, Pan ZZ. Synaptic adaptations and mechanisms of analgesic tolerance to chronic opioids, 2003. e-Pub 2003.
      23. Bie, B, Pan ZZ. Anti-analgesic actions of kappa receptors by a presynaptic mechanism, 2002. e-Pub 2002.

      Book Chapters

      1. Pan, ZZ, Zhou, C, Wu, Y, Zhang, Z, Cai, Y. Pain-Induced Chromatin Modifications. In: Epigenetics of Chronic Pain. Elsevier, 111-124, 2019.
      2. Pan ZZ. Opioid Receptors. In: Molecular Pain. Higher Education Press, 2007.
      3. Pan ZZ. Mechanisms of Opioid Tolerance. In: Molecular Pain. Higher Education Press, 2007.
      4. Pan ZZ. Opioid Tolerance in Adult and Neonatal Rats. In: Opioid Research: Methods and Protocols / Methods in Molecular Medicine. Humana Press, 223-232, 2003.

      Books (edited and written)

      1. Pan ZZ. Opioid Research: Methods and Protocols. Humana Press, 2003.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 15, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Pan ZZ Laboratory

      • Pain Medicine department

      • Anesthesiology, Critical Care Medicine & Pain Medicine division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top